Floatz logo

Liposomal T4N5 Lotion

Skin Squamous Cell Carcinoma

National Cancer Institute (NCI)UNKNOWNPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

56 Active assets in the Skin Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Prednisone
Dana-Farber Cancer Institute
Phase 4BB
Sirolimus
Dana-Farber Cancer Institute
Phase 4BB
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Regeneron Pharmaceuticals
Phase 3BB
Technetium-99
Institut de Cancérologie de Lorraine
Phase 3BB
Indocyanine Green
Institut de Cancérologie de Lorraine
Phase 3BB

View all 50 →

Same molecule, other indications

Liposomal T4N5 Lotion is also rated in:

actinic keratosisDormant
B
Indicative · Phase 2
57 / 100
View asset →
skin basal cell carcinomaDormant
B
Indicative · Phase 2
57 / 100
View asset →
skin cancerDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →